Industrials·Construction & Engineering·$10.2B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.61 | N/A | -0.98% |
management commentary, guidance changes, and full analysis available with Pro.
| -0.98% |
Tone: Cautiously Optimistic
Overall, management expressed a cautious optimism about the company's current projects. They acknowledged challenges but are focused on improving efficiency.
Management highlighted ongoing projects and their importance to future growth.
They emphasized a focus on operational efficiency moving forward.
Stantec's earnings report showed a slight miss on EPS, but the stock still reacted positively, rising by 0.3%. This indicates that investors may be optimistic about the company's ongoing projects and management's focus on efficiency. The lack of revenue data and guidance leaves some uncertainty, but the overall sentiment appears stable for now.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
ALNYLAM PHARMACEUTIC
May 6, 2013